Trillium Asset Management, LLC / GILD
Trillium Asset Management, LLC’s Gilead Sciences Inc Position
Does Trillium Asset Management, LLC own Gilead Sciences Inc (GILD)? Yes — 81.4K shares worth $11M (+0.38% of its 13F portfolio) as of Q1 2026, up from 78.7K shares the prior filed quarter.
Position Value
$11M
Q1 2026
Shares
81.4K
% of Portfolio
+0.38%
Quarters Held
30
currently held
Position History GILD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 81.4K | $11M | +0.38% |
| Q4 2025 | 78.7K | $10M | +0.31% |
| Q3 2025 | 98.6K | $11M | +0.29% |
| Q2 2025 | 102.5K | $11M | +0.31% |
| Q1 2025 | 105.2K | $12M | +0.34% |
| Q4 2024 | 145.5K | $13M | +0.35% |
| Q3 2024 | 155.9K | $13M | +0.32% |
| Q2 2024 | 161.2K | $11M | +0.28% |
| Q1 2024 | 164.1K | $12M | +0.31% |
| Q4 2023 | 131.3K | $11M | +0.29% |
| Q3 2023 | 131.7K | $10M | +0.30% |
| Q2 2023 | 133.1K | $10M | +0.29% |
| Q1 2023 | 95.7K | $8M | +0.23% |
| Q4 2022 | 95.7K | $8M | +0.25% |
| Q3 2022 | 100.5K | $6M | +0.20% |
| Q2 2022 | 101.8K | $6M | +0.19% |
| Q1 2022 | 106.9K | $6M | +0.17% |
| Q4 2021 | 205.3K | $15M | +0.35% |
| Q3 2021 | 202.7K | $14M | +0.37% |
| Q2 2021 | 196.5K | $14M | +0.37% |
| Q1 2021 | 196.1K | $13M | +0.40% |
| Q4 2020 | 195.6K | $11M | +0.41% |
| Q3 2020 | 227.0K | $14M | +0.60% |
| Q2 2020 | 228.7K | $18M | +0.75% |
| Q1 2020 | 249.8K | $19M | +0.98% |
| Q4 2019 | 239.3K | $16M | +0.69% |
| Q3 2019 | 270.1K | $17M | +0.80% |
| Q2 2019 | 157.7K | $11M | +0.51% |
| Q1 2019 | 173.9K | $11M | +0.57% |
| Q4 2018 | 173.7K | $11M | +0.63% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trillium Asset Management, LLC’s full portfolio or all institutional holders of GILD.